Literature DB >> 12569155

HIV protease inhibitors and atherosclerosis.

David Y Hui1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12569155      PMCID： PMC151877          DOI： 10.1172/JCI17746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  The acute-phase protein response to human immunodeficiency virus infection in human subjects.

Authors:  F Jahoor; B Gazzard; G Phillips; D Sharpstone; M Delrosario; M E Frazer; W Heird; R Smith; A Jackson
Journal:  Am J Physiol       Date:  1999-06

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 3.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

4.  Severe premature coronary artery disease with protease inhibitors.

Authors:  K Henry; H Melroe; J Huebsch; J Hermundson; C Levine; L Swensen; J Daley
Journal:  Lancet       Date:  1998-05-02       Impact factor: 79.321

5.  Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism.

Authors:  L Fajas; K Schoonjans; L Gelman; J B Kim; J Najib; G Martin; J C Fruchart; M Briggs; B M Spiegelman; J Auwerx
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

6.  HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus.

Authors:  T M Riddle; D G Kuhel; L A Woollett; C J Fichtenbaum; D Y Hui
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  CD36 deficiency induced by antiretroviral therapy.

Authors:  Lena Serghides; Salima Nathoo; Sharon Walmsley; Kevin C Kain
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

8.  An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Authors:  P André; M Groettrup; P Klenerman; R de Giuli; B L Booth; V Cerundolo; M Bonneville; F Jotereau; R M Zinkernagel; V Lotteau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.

Authors:  James Dressman; Jeanie Kincer; Sergey V Matveev; Ling Guo; Richard N Greenberg; Theresa Guerin; David Meade; Xiang-An Li; Weifei Zhu; Annette Uittenbogaard; Melinda E Wilson; Eric J Smart
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808
  9 in total
  4 in total

1.  Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.

Authors:  Bokai Lei; Weibin Zha; Yun Wang; Cong Wen; Elaine J Studer; Xuan Wang; Fang Jin; Guangji Wang; Luyong Zhang; Huiping Zhou
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

2.  Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats.

Authors:  I Tong Mak; Jay H Kramer; Xi Chen; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-18       Impact factor: 3.619

3.  Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.

Authors:  Maria Letizia Giardino Torchia; Elena Ciaglia; Anna Maria Masci; Laura Vitiello; Manuela Fogli; Andrea la Sala; Domenico Mavilio; Luigi Racioppi
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 4.  Protease inhibitors and their peptidomimetic derivatives as potential drugs.

Authors:  Georgie Fear; Slavko Komarnytsky; Ilya Raskin
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.